A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction-Reference-Cited by-同舟云学术

A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction

Published:2014 Issue:1 Volume:29 Page:23
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Lee Jun-Won¹,Lee Seung-Hwan¹,Youn Young-Jin¹,Ahn Min-Soo¹,Kim Jang-Young¹,Yoo Byung-Su¹,Yoon Junghan¹,Kwon Woocheol²,Hong In-Soo²,Lee Kyounghoon³,Kwan Jun⁴,Park Keum Soo⁴,Choi Donghoon⁵,Jang Yang Soo⁵,Hong Mun K.⁶

Affiliation:

1. Division of Cardiology, Yonsei University Wonju College of Medicine, Wonju, Korea.

2. Department of Radiology, Yonsei University Wonju College of Medicine, Wonju, Korea.

3. Department of Cardiology, Gachon Medical School, Gil Medical Center, Incheon, Korea.

4. Division of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Korea.

5. Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.

6. Division of Cardiology, Department of Medicine, St. Luke's Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Funder

FCB-Pharmicell Company Limited (Seongnam, Korea)

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2014.29.1.23

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing;Physiological Reviews;2024-04-01

2. Cell-Based Therapies in Myocardial Infarction and Tissue Regeneration;Synthesis Lectures on Biomedical Engineering;2024

3. Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management;Stem Cells;2024

4. The recent advances in cell delivery approaches, biochemical and engineering procedures of cell therapy applied to coronary heart disease;Biomedicine & Pharmacotherapy;2023-12

5. Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction;Journal of Cardiovascular Translational Research;2023-10-11